Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,673 | 67,975 | 56,270 | 35,934 | 12,037 |
| Depreciation Amortization | 1,437 | 5,508 | 4,039 | 2,684 | 1,021 |
| Accounts receivable | -684 | -334 | -1,717 | -13,095 | -2,841 |
| Accounts payable and accrued liabilities | 4,552 | 4,844 | 1,824 | 1,256 | 1,131 |
| Other Working Capital | -26,786 | 87,159 | 91,639 | 104,762 | 152,509 |
| Other Operating Activity | 624 | 7,883 | 7,170 | 17,158 | 4,428 |
| Operating Cash Flow | $-23,530 | $173,035 | $159,225 | $148,698 | $168,285 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,600 | -35,745 | -60,405 | -78,027 | -67,019 |
| PPE Investments | -4,320 | -12,001 | -4,170 | -947 | -738 |
| Investing Cash Flow | $9,280 | $-47,746 | $-64,575 | $-78,974 | $-67,756 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2,415 | -2,415 | -2,415 | -2,415 |
| Common Stock Issued | 253,478 | 68,797 | 66,964 | 64,197 | 61,526 |
| Financing Cash Flow | $253,478 | $66,382 | $64,549 | $61,781 | $59,111 |
| Beginning Cash Position | 221,804 | 30,133 | 30,133 | 30,133 | 30,133 |
| End Cash Position | 461,032 | 221,804 | 189,332 | 161,639 | 189,773 |
| Net Cash Flow | $239,228 | $191,671 | $159,199 | $131,506 | $159,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,530 | 173,035 | 159,225 | 148,698 | 168,285 |
| Capital Expenditure | -4,320 | -12,001 | -4,170 | -947 | -738 |
| Free Cash Flow | -27,850 | 161,034 | 155,055 | 147,752 | 167,547 |